JUBBONTI
JUBBONTI
Approved
DIN Number
02545411
Drug Class
Human
Market Date
Jul 25, 2024
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02545411
AIG Number0152691001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
M05BX04 DENOSUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DENOSUMABActive
Strength: 60 MG / ML
Monograph: DENOSUMAB